Wednesday, June 19, 2013 Last update: 10:42 AM
Company Tech News as it Breaks
Trade Events
KYTHERA BIOPHARMACEUTICALS, Inc.
News articles for KYTHERA BIOPHARMACEUTICALS, Inc.:
Saturday, April 13, 2013
- KYTHERA Biopharmaceuticals, Inc. Presents Positive Magnetic Resonance Imaging (MRI) Results from Phase IIb Study of ATX-101 in the Reduction of Submental Fat or “Double Chin”KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today presented positive results that found MRI measurements of patients treated with ATX-101 demonstrated a statistically significant reduction in submental fat ... read more
Thursday, March 21, 2013
- KYTHERA Biopharmaceuticals Announces 2012 Operating ResultsKYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today reported financial results for its quarter and year ended December 31, 2012. ... read more
Tuesday, March 12, 2013
- Medical Aesthetics Veteran Frederick Beddingfield, III, MD, PhD Appointed New Chief Medical Officer of KYTHERA BiopharmaceuticalsKYTHERA Biopharmaceuticals, Inc. (NASDAQ:KYTH), a biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, today announced the ... read more
Saturday, March 2, 2013
- KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label study (ATX-101-11-26) to evaluate the safety and efficacy of ATX-101, an ... read more
Friday, March 1, 2013
- KYTHERA Biopharmaceuticals, Inc. to Present New Data at 2013 American Academy of Dermatology (AAD) Annual Meeting Demonstrating Results for ATX-101 in the Reduction of Submental Fat (SMF) or “Double CKYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced four abstracts will be presented at the 71st American Academy of Dermatology (AAD) Annual Meeting in Miami Beach, Fla. The abstracts, ... read more
Tuesday, February 26, 2013
- KYTHERA Biopharmaceuticals to Present at Cowen and Company 33rd Annual Health Care ConferenceKYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced that Keith Leonard, President and Chief Executive Officer, will present at the Cowen and Company ... read more
Tuesday, February 19, 2013
- KYTHERA Biopharmaceuticals to Present at 2013 RBC Global Healthcare ConferenceKYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced that Keith Leonard, President and Chief Executive Officer, will present at the 2013 RBC Global ... read more
Wednesday, February 6, 2013
- KYTHERA Biopharmaceuticals to Present at Leerink Swann Global Healthcare ConferenceKYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced that Keith Leonard, President and Chief Executive Officer, will present at the Leerink Swann Global ... read more
Wednesday, December 26, 2012
- KYTHERA Biopharmaceuticals Added to Russell 3000, 2000, Global and Microcap IndexesKYTHERA Biopharmaceuticals, Inc. (NASDAQ:KYTH) today announced that the company has been added to each of the broad-market Russell 3000® Index, the Russell ... read more